Biliary Fistulas in Surgery of Liver Echinococcosis (BFISOLE)

Improvement of Methodological Approaches to Diagnostics and Tactics of Treatment of Biliary Fistulas in Surgery of Liver Echinococcosis

The objective of the study is to improving the results of surgical treatment of liver echinococcosis complicated by biliary fistula by optimizing diagnostic approaches to early verification of this complication and improving the tactical and technical aspects of its elimination.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tashkent, Uzbekistan, 100000
        • Recruiting
        • Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov
        • Contact:
          • Azam Babadjanov, Professor
          • Phone Number: +998901751703
          • Email: azam746@mail.ru

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age under 18 years;
  • Informed consent for inclusion in the study;
  • The presence of liver echinococcosis, for which conservative surgical treatment will be performed;
  • The presence of the entire spectrum of necessary preoperative diagnostic measures;
  • A full description of all stages of surgical intervention, indicating the type of intervention (open or laparoscopic surgery, location and size of the echinococcal cyst in the liver, type of antiparasitic treatment, presence or absence of a biliary fistula in the residual cavity, actions taken in relation to the fistula, the option of eliminating the residual cavity and drainage;
  • Availability of objective data on the characteristics of the postoperative course, including dynamic indicators of the patient's condition, temperature, amount and nature of discharge through the drainage, the time of drainage removal, the type of complications (if any) and the method of their treatment, the duration of the hospital period, data on the characteristics of the posthospital period up to 3 months of observation;
  • Absence of concomitant pathology that may affect the outcome of the surgery.

Exclusion Criteria:

  • Age under 18 years;
  • Refusal to participate in the study;
  • Extrahepatic echinococcosis without liver damage;
  • Absence of the full range of preoperative diagnostic data;
  • Difficulties with objective analysis of the features of the performed surgical treatment;
  • Incomplete data on monitoring the postoperative hospital and remote (up to 3 months) period;
  • The presence of concomitant pathology that may affect the outcome of the operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: operation for liver echinococcosis complicated by a biliary fistula
In conservative surgical operations for liver echinococcosis, the biliary fistula is identified, onto which a U-shaped suture is applied, after which medical cyanoacrylate glue is applied between the suture stitches to the fibrous capsule in the fistula area and the suture threads are tied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the incidence of bile leakage after conservative surgical interventions for liver echinococcosis
Time Frame: 3 months
assessing the effectiveness of the method for eliminating biliary fistulas in the fibrous capsule during organ-preserving surgeries for liver echinococcosis, characterized by creating a two-level strengthening of the fistula area by applying U-shaped sutures and a cyanoacrylate adhesive composition
3 months
Measuring the time of closure of biliary fistulas in the postoperative period
Time Frame: 3 months
In the group of patients with the development of biliary fistulas after surgery, the time of their closure in days will be studied
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the costs of treating patients with liver echinococcosis
Time Frame: 3 months
Economic costs will be assessed for patients with liver echinococcosis who undergo conservative surgical interventions, taking into account the absence or development of bile leakage in the postoperative period
3 months
Measurement of the quality of life of patients after conservative surgical interventions for liver echinococcosis.
Time Frame: 3 months
The quality of life will be analyzed using the SF-36 (The 36-Item Short Form Survey) questionnaire in patients after conservative surgical interventions, taking into account the absence or development of bile leakage in the postoperative period. It stems from a study called the Medical Outcomes Study for the objective measure of the quality of life. Scores for the various domains are transformed and combined using a scoring key to obtain a total score indicating a range from low to high quality of life (from 0 to 100 points). Scores for two components, the physical component and the mental component, can also be calculated.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 22, 2023

Primary Completion (Estimated)

September 22, 2026

Study Completion (Estimated)

December 23, 2026

Study Registration Dates

First Submitted

February 27, 2024

First Submitted That Met QC Criteria

September 21, 2024

First Posted (Actual)

September 25, 2024

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 29, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biliary Fistula

Subscribe